0001914060-22-000001.txt : 20220301 0001914060-22-000001.hdr.sgml : 20220301 20220301095917 ACCESSION NUMBER: 0001914060-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 EFFECTIVENESS DATE: 20220301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biolexis Therapeutics, Inc. CENTRAL INDEX KEY: 0001914060 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-435320 FILM NUMBER: 22694644 BUSINESS ADDRESS: STREET 1: 9980 SOUTH, 300 WEST, SUITE #200 CITY: SANDY STATE: UT ZIP: 84070 BUSINESS PHONE: 801-550-8088 MAIL ADDRESS: STREET 1: 9980 SOUTH, 300 WEST, SUITE #200 CITY: SANDY STATE: UT ZIP: 84070 D 1 primary_doc.xml X0708 D LIVE 0001914060 Biolexis Therapeutics, Inc. 9980 SOUTH, 300 WEST, SUITE #200 SANDY UT UTAH 84070 801-550-8088 DELAWARE None None Corporation true 2021 David J. Bearss 9980 South, 300 West, Suite #200 Sandy UT UTAH 84070 Executive Officer President and Chief Executive Officer David Taylor 9980 South, 300 West, Suite #200 Sandy UT UTAH 84070 Executive Officer Chief Financial Officer and Secretary Hariprasad Vankayalapati 9980 South, 300 West, Suite #200 Sandy UT UTAH 84070 Executive Officer Director Chief Scientific Officer Biotechnology Decline to Disclose 06b false 2022-02-03 false true true Convertible Promissory Notes false 0 2000000 1500000 500000 false 17 0 0 0 false Biolexis Therapeutics, Inc. /s/ David O.Taylor David O. Taylor CFO 2022-02-14